The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results from the phase 2 IZALCO study: Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.
 
Marcelo Capra
Speakers' Bureau - Abbvie; Johnson & Johnson/Janssen; Lilly
Research Funding - AstraZeneca (Inst); BeiGene (Inst); BMSi (Inst); GlaxoSmithKline (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Dr. Reddy's Laboratories; Sanofi
 
Gurdeep Parmar
Honoraria - Bristol-Myers Squibb; Sanofi
Consulting or Advisory Role - Janssen; Sanofi
 
Fernanda Seguro
No Relationships to Disclose
 
Vania Hungria
Consulting or Advisory Role - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Johnson&Johnson; Pfizer; Regeneron; Roche; Sanofi; Takeda
Speakers' Bureau - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi; Takeda
 
Meletios Dimopoulos
Honoraria - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Takeda
 
Sosana Delimpasi
Honoraria - Amgen; AOP Orphan Pharmaceuticals; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Sanofi
Consulting or Advisory Role - Amgen; AOP Orphan Pharmaceuticals; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Sanofi
 
Junichiro Yuda
Research Funding - Abbvie; Amgen; AstraZeneca; Brighpath Bio; Bristol-Myers Squibb/Celgene; Celeid Therapeutics; Chugai Pharma; Daiichi Sankyo; Genmab; Incyte; Janssen; Mitsubishi Tanabe; MSD; Novartis; Sanofi; Sumitomo Pharma; Takeda
 
Ivan Špicka
Consulting or Advisory Role - BMS GmbH & Co. KG; Janssen-Cilag; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Janssen-Cilag; Sanofi
Travel, Accommodations, Expenses - Janssen-Cilag; Sanofi
 
Roman Hajek
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; PharmaMar; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Novartis; Oncopeptides; PharmaMar; Sanofi; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; PharmaMar; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Takeda
 
Christine Soufflet
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Disa Yu
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Victorine Koch
Employment - Excelya (on behalf of Sanofi)
Stock and Other Ownership Interests - Ipsen; Sanofi
 
Florence Suzan
Employment - Sanofi/Aventis
Stock and Other Ownership Interests - Sanofi/Aventis
 
Jiri Minarik
Honoraria - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Sanofi; Takeda
 
Hang Quach
Consulting or Advisory Role - Antengene (Inst); Bristol-Myers Squibb/Celgene; GlaxoSmithKline (Inst); Janssen-Cilag; Karyopharm Therapeutics (Inst); Pfizer; Roche; Sanofi (Inst)
Research Funding - Amgen; Bristol-Myers Squibb/Celgene; Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi